Latest News
'25 at 25': OCTOPUS – speeding up new treatments for progressive MS
As part of our ’25 at 25’ series, we explore how the OCTOPUS trial in progressive multiple sclerosis (MS) aims to speed up the delivery of new treatments, bringing hope to the MS community.
'25 at 25': Conducting the first large international randomised controlled trial on tuberculosis treatment for children
As part of our ’25 at 25’ series, we look back at The SHINE trial, which was the first randomised controlled trial to assess the length of treatment needed for children with TB.
'25 at 25': Making HIV treatment accessible to people living in sub-Saharan Africa
In the early 2000s, very few of the 25 million people living with HIV in sub-Saharan Africa were on antiretroviral therapy. Our '25 at 25' series explores how our clinical trials helped widen access to HIV treatment.
HIV vaccines tested in PrEPVacc fail to reduce infections
HIV vaccines tested in PrEPVacc fail to reduce infections
'25 at 25': Improving clinical trial monitoring
Our ‘25 at 25’ series examines how the Unit’s work has evaluated and helped improve clinical trial monitoring practices.